SaponiQx, a leader in saponin-based adjuvant discovery, is pleased to announce a strategic collaboration with Probius, a pioneer in quantum molecular ...
I read your recent column on shingles. I am 66 and in fairly good health. I had both Shingrix shots about five years ago and take hydroxyurea for polycythemia vera (PV).
Curevo Vaccine (Curevo), a privately-held clinical-stage biotechnology company dedicated to developing varicella zoster virus (VZV) vaccines with improved tolerability and accessibility, today ...
Shingrix in 2017 received US FDA approval to prevent shingles in adults aged 50 and older. Since 2021, it has been approved for use in immunocompromised patients aged 18 and up. GSK estimates around ...
A weakened immune system facilitates the chickenpox virus to reactivate as shingles. A shingles vaccine is available. The Food and Drug Administration (FDA) approved the vaccine Shingrix in 2017 ...
Curevo’s CEO, George Simeon, will discuss updated data from Curevo’s 876-patient head-to-head trial of amezosvatein, a non-mRNA adjuvanted subunit vaccine for shingles, versus Shingrix ®.